ROCKVILLE, Md., Jan. 11, 2022 /PRNewswire/ — Save a Child’s Heart (SACH) Board of Directors of the US branch elected Vivian G. Bass of Bethesda, Maryland to serve as President effective January 1, 2022. “Vivian is an outstanding visionary and legendary leader who is highly respected and admired by individuals of all ages, cultures, religions, and socioeconomic statuses,” […]
Financial
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on December 31, 2021 it granted stock options to purchase an aggregate of 90,000 shares of common stock to 9 new employees, whose employment commenced in December 2021, as a material inducement to […]
Eko Chief Medical Officer, Dr. Adam Saltman, Accepted into Forbes Technology Council
Forbes Technology Council, Invitation-Only Community for World-Class Technology Executives, Welcomes Dr. Saltman of Eko OAKLAND, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) — Eko, a cardiopulmonary digital health company, announced today that the company’s chief medical officer, Adam Saltman M.D., Ph.D., has joined the Forbes Technology Council, an invitation-only community for world-class CIOs, […]
iRhythm Technologies Comments on Medicare Administrative Contractor 2022 Rate Update
SAN FRANCISCO, Jan. 10, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, commented on the recent update by Novitas Solutions (Novitas), a Medicare Administrative Contractor (MAC), regarding updated rates applicable to the Current Procedural Terminology (CPT) codes 93243 and […]
H-CYTE Enters Into Letter of Intent for Acquisition of Catheter Precision, Inc.
Targets one of Healthcare’s Largest Multi-Billion Dollar Markets: Cardiac Electrophysiology TAMPA, Fla., Jan. 11, 2022 (GLOBE NEWSWIRE) — H-CYTE, Inc. (OTCQB: HCYT), a medical biosciences company, today announced that it has entered into a letter of intent for the acquisition of Catheter Precision, Inc. Catheter Precision is a medical device […]
Esperion Provides Preliminary Fourth Quarter 2021 Financial Results and CLEAR Outcomes Program Update
– Unprecedented CLEAR Outcomes Trial Remains On-Track for Complete Major Adverse Cardiac Events (MACE) Accumulation in 2H 2022; Achieved 85% MACE Accumulation in December – – Fourth-quarter 2021 U.S. Net Product Revenue Estimated Between $12.0 to $12.5 Million – – Company Reiterates Full-Year 2022 Operating Expense Guidance of $220 to […]
Amarin Provides Preliminary 2021 Revenue and Outlook for 2022
DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today provided a business update, including preliminary unaudited full-year 2021 revenue results. Amarin plans to discuss these results and expectations with investors in connection with the 40th Annual J.P. Morgan Healthcare Conference at which Amarin is […]
CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results
MINNEAPOLIS, Jan. 10, 2022 (GLOBE NEWSWIRE) — CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced certain preliminary unaudited fourth quarter and full year 2021 revenue results, and provided a 2022 business outlook. Fourth Quarter […]
Acarix appoints US based Helen Ljungdahl Round as new CEO
The Board of Acarix AB (publ) has today appointed Helen Ljungdahl Round as new Chief Executive Officer, with immediate effect. Helen is currently President of Acarix USA Inc. and will continue to be based in the US in her capacity as new group CEO of Acarix. Ms. Helen Ljungdahl Round […]
VitalConnect Announces Closure of $39 Million Round of Growth Financing
Series E Financing led by EW Healthcare Partners with Robert S. White to Join Board SAN JOSE, Calif.–(BUSINESS WIRE)–VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced the completion of a $39 million round of financing, funded by EW Healthcare Partners in addition to other new […]



